3
Shared Docs
3
Same-Page
3 / 3
Mentions
pecific terms ol the Notes are provided herein. If the terms described herein are different or inconsistent with those described in the accompanying Product Supplement or the Offering Memorandum, the terms described herein shall control. Capitalized terms used in this pricing supplement, but not defined herein, sha
nce Commodity on the Pricing Date, as determined by the Calculation Agent. - Anal Commodity Value: The arithmetic average of the Closing Values of the Reference Commodity on each of the rue Final Averaging Dates, as determined by the Calculation Agent. CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL S
with the more detailed information that is contained in (i) this Pricing Supplement, (ii) the "Description of the Notes" section in the accompanying Product Supplement and (iii) the "Description of the Notes"section in the accompanying Offering Memorandum. What are the Notes? The Notes are senior unsecured obliga
not pay any interest. Subject to the Issuer's and the Guarantor's credit risk (ability to pay), payment at maturity is linked to the performance of the Reference Commodity indicated on the cover page of this Pricing Supplement. The Notes are non-principal protected; therefore, your principal is at risk and you could lo
lly relating to the Reference Commodity Please refer to the section "Risk Factors — Risks relating to each Reference Commodity" in the accompanying Product Supplement for additional risk factors relating to the Reference Commodity. Tax Treatment There is no direct legal authority as to the proper tax treatment of
e section "Risk Factors — Risks relating to each Reference Commodity" in the accompanying Product Supplement for additional risk factors relating to the Reference Commodity. Tax Treatment There is no direct legal authority as to the proper tax treatment of the Notes, and therefore significant aspects of the tax treatm
Entities connected to both Product Supplement and the Reference Commodity